On Monday, Exxon Mobil Corporation (NYSE:XOM)’s shares inclined 2.30% to $76.05.
ExxonMobil declared the successful and safe startup of the onshore central processing facility at the Banyu Urip field in Indonesia, assisting enhance production to more than 130,000 barrels of oil per day.
With the central processing facility now online, production will continue to enhance in the coming months. Once full field production is reached, Banyu Urip will represent about 20 percent of Indonesia’s 2016 oil production target.
“This milestone demonstrates ExxonMobil’s project administration expertise and illustrates the strong partnerships we share with our Indonesia co-venturers and contractors, the government, and the community,” said Neil W. Duffin, president of ExxonMobil Development Company. “Our top preceding has always been the safe and cost-effective delivery of a reliable project that would result in decades of oil production for Indonesia.”
Exxon Mobil Corporation engages in refining and marketing crude oil and natural gas in the United States, Canada/South America, Europe, Africa, Asia, and Australia/Oceania.
Becton Dickinson and Co (NYSE:BDX)’s shares gained 1.00% to $153.19.
BD (Becton, Dickinson and Company) (BDX) declared the launch of the BD FACSCelesta™ flow cytometer during the 2015 American Society for Cell Biology (ASCB) annual meeting. Uniquely designed to leverage the broad BD Horizon Brilliant™ reagent portfolio, this new system offers simultaneous measurement of up to 14 different single cell characteristics.
The BD FACSCelesta is an advanced system for driving scientific insights for a wide range of applications. Accessible now for research segment use, the BD FACSCelesta is the latest advancement in the award winning BD cell analyzer portfolio. It offers performance that is typically only seen in higher end systems, enabling compriseency of results and seamless transfer of applications between BD platforms with 14 parameters in a three-laser benchtop system.
For more noteworthysingle cell studies and higher quality data, the BD FACSCelesta system opens new avenues of investigation and a deeper level of biological study. When combined with the patented technology of BD Horizon Brilliant™ polymer dyes, it enables greater resolution of formerly unobserved cell populations and is an ideal solution for researchers wanting more fluorophore choices when using multicolor flow cytometry.
“Designed from the ground up, the BD FACSCelesta allows researchers to benefit from new innovations in instrument and reagent technology,” said Claude Dartiguelongue, worldwide president of BD Biosciences. “This means that researchers can now, with improved brightness and low spectral overlap, optimally identify, characterize, and resolve even dim staining populations of interest.”
Becton, Dickinson and Company develops, manufactures, and sells medical devices, instrument systems, and reagents worldwide. The company’s BD Medical segment offers syringes and pen needles for diabetes; needles, syringes, and intravenous catheters for medication delivery; prefilled IV flush syringes; regional anesthesia needles and trays; sharps disposal containers; closed-system transfer devices; skin antiseptic products; surgical and laproscopic instrumentations; generic prefilled injectables; intravenous medication safety and infusion therapy delivery, and automated medication dispensing and supply administration systems; prefillable drug delivery systems; respiratory ventilation, and diagnostics equipment and consumables; and consumables for patient monitoring and anesthesia delivery.
At the end of Monday’s trade, Devon Energy Corp (NYSE:DVN)‘s shares dipped -5.99% to $31.54.
Devon Energy Corporation declared it has agreed to acquire 80,000 net surface acres, with up to 10 prospective zones, in the Anadarko Basin STACK play from privately held Felix Energy, a portfolio company of EnCap Investments, for $1.9 billion. In a separate transaction, the Company has also agreed to acquire 253,000 net acres in the Powder River Basin for $600 million. The transactions will be funded with about $1.35 billion of Devon equity issued to sellers and about $1.15 billion of cash on hand and borrowings.
- Agrees to acquire premier oil-focused leasehold in STACK and Powder River Basin plays
- Creates industry-leading positions in best emerging oil development plays in North America
- Adds thousands of high-quality drilling locations with substantial resource upside
- Commences divestiture program with targeted proceeds of $2 to $3 billion
- Proceeds from asset sales to bolster financial position
Devon Energy Corporation, an independent energy company, primarily engages in the exploration, development, and production of oil, natural gas, and natural gas liquids (NGLs) in the United States and Canada.
